DPP10 antisense RNA 2 (DPP10-AS2)

DPP10 antisense RNA 2 (DPP10-AS2) is annotated as a long non-coding RNA (lncRNA) transcribed in the antisense direction relative to the DPP10 gene locus, but there is currently no published functional, biological, or disease-relevance data specific to DPP10-AS2. Most studies in this locus instead focus on DPP10-AS1, a related antisense RNA, or on DPP10 itself, with no evidence in current literature of DPP10-AS2 being a characterized molecule or therapeutic target[4]. Analysis: There is confusion or conflation in some annotation databases between DPP10-AS1 and DPP10-AS2, but published biomedical research does not reference DPP10-AS2 as a distinct or biologically characterized entity either as a target or as a functional RNA. No aliases, molecular functions, disease roles, or relevance as a target are described in the literature. Only gene annotation entries exist, without biological context[4]. Conclusion: DPP10-AS2 is not a validated or characterized target molecule in current literature, and search results indicate it is either an unstudied gene annotation or potentially a confusion with the similarly named DPP10-AS1 (which is biologically relevant in cancer and as a regulatory lncRNA[1][5]). Therefore, is_target: false and is_incorrect: true are justified for "DPP10 antisense RNA 2" in biomedical/pharmacological contexts.